| In millions, except per share items | Sep-30-20 | Jun-30-20 | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 | Dec-31-18 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues: |
| Recovery Audit Services — Americas | 28.0 | 27.0 | 26.2 | 30.4 | 30.0 | 28.9 | 27.4 | 32.2 |
| Recovery Audit Services — Europe/Asia-Pacific | 12.7 | 11.2 | 9.8 | 14.9 | 10.8 | 11.8 | 9.8 | 15.9 |
| Adjacent Services | 0.9 | 0.9 | 0.8 | 1.4 | 1.5 | 1.2 | 1.7 | 1.5 |
| Total revenues | 41.5 | 39.0 | 36.8 | 46.7 | 42.3 | 42.0 | 38.8 | 49.6 |
| Revenue growth [+] | -1.8% | -7.1% | -5.1% | -5.9% | -2.4% | -0.3% | 5.7% | -32.8% |
| Recovery Audit Services — Americas | -6.5% | -6.8% | -4.2% | -5.7% | 4.1% | 0.1% | 5.5% | |
| Recovery Audit Services — Europe/Asia-Pacific | 17.1% | -5.7% | 0.3% | -6.2% | -11.4% | 3.4% | -2.7% | |
| Adjacent Services | -43.0% | -25.9% | -50.3% | -8.8% | -35.4% | -31.1% | 127.2% | |
| Cost of goods sold | 20.8 | 20.6 | 22.5 | 23.1 | 25.5 | 26.3 | 25.2 | 26.5 |
| Gross profit | 20.7 | 18.4 | 14.3 | 23.6 | 16.8 | 15.7 | 13.6 | 23.1 |
| Gross margin | 49.9% | 47.2% | 38.8% | 50.5% | 39.6% | 37.3% | 35.0% | 46.6% |
| Selling, general and administrative [+] | 13.8 | 14.7 | 13.5 | 14.4 | 13.5 | 15.7 | 13.9 | 13.9 |
| General and administrative | | | | 14.4 | | | | 13.9 |
| Other operating expenses | | | | 0.6 | | | | -0.8 |
| Adjusted EBITDA | 8.9 | 5.6 | 2.2 | 10.8 | 3.7 | 1.6 | 1.0 | 11.8 |
| Adjusted EBITDA margin | 21.5% | 14.3% | 5.9% | 23.2% | 8.8% | 3.8% | 2.7% | 23.8% |
| Stock-based compensation | 2.0 | 1.9 | 1.3 | 1.4 | 0.5 | 1.7 | 1.4 | 0.9 |
| EBITDA [+] | 7.0 | 3.7 | 0.8 | 9.5 | 3.2 | -0.1 | -0.3 | 10.9 |
| EBITDA growth | 117.3% | -4403.5% | -341.7% | -13.3% | -31.1% | -104.5% | -152.7% | 38.2% |
| EBITDA margin | 16.8% | 9.5% | 2.3% | 20.3% | 7.6% | -0.2% | -0.9% | 22.0% |
| Depreciation and amortization | 1.3 | 2.0 | 2.1 | 2.7 | 2.6 | 2.4 | 2.2 | 2.1 |
| EBITA | 5.7 | 1.7 | -1.3 | 6.7 | 0.6 | -2.5 | -2.6 | 8.8 |
| EBITA margin | 13.7% | 4.5% | -3.5% | 14.4% | 1.3% | -5.9% | -6.6% | 17.8% |
| Amortization of intangibles | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| EBIT [+] | 4.8 | 0.9 | -2.1 | 5.8 | -0.3 | -3.3 | -3.4 | 8.0 |
| EBIT growth | -1687.9% | -127.2% | -37.6% | -26.6% | -114.7% | 153.0% | 152.6% | 49.7% |
| EBIT margin | 11.7% | 2.3% | -5.8% | 12.5% | -0.7% | -8.0% | -8.8% | 16.0% |
| Non-recurring items [+] | 0.6 | | | 10.3 | -0.3 | | | 1.6 |
| Asset impairment | 0.6 | | | | | | | |
| Interest expense, net [+] | 0.2 | 0.3 | 0.3 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 |
| Interest expense | 0.2 | 0.3 | 0.3 | 0.5 | 0.4 | 0.6 | 0.5 | 0.5 |
| Interest income | | | | 0.1 | | | | 0.2 |
| Other income (expense), net [+] | 0.4 | 0.8 | -1.5 | 0.7 | -0.9 | 0.1 | -0.2 | -0.3 |
| Other | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax income | 4.5 | 1.4 | -3.9 | -4.1 | -1.3 | -3.9 | -4.1 | 5.7 |
| Income taxes | 1.5 | 1.0 | 0.0 | 0.2 | 0.2 | 0.3 | 0.2 | -0.3 |
| Tax rate | 32.4% | 70.6% | 1.1% | | | | | |
| Earnings from continuing ops | 3.0 | 0.4 | -3.9 | -4.4 | -1.5 | -4.2 | -4.2 | 5.9 |
| Earnings from discontinued ops | | | | 0.0 | 0.9 | -0.1 | -0.2 | 1.9 |
| Net income | 3.0 | 0.4 | -3.9 | -4.4 | -0.6 | -4.3 | -4.4 | 7.9 |
| Net margin | 7.3% | 1.1% | -10.5% | -9.4% | -1.5% | -10.2% | -11.3% | 15.8% |
| |
| Basic EPS [+] | $0.13 | $0.02 | ($0.17) | ($0.19) | ($0.07) | ($0.18) | ($0.19) | $0.26 |
| Growth | -297.4% | -110.1% | -7.9% | -174.2% | -160.8% | 48.3% | 81.9% | 0.9% |
| Diluted EPS [+] | $0.13 | $0.02 | ($0.17) | ($0.19) | ($0.07) | ($0.18) | ($0.19) | $0.25 |
| Growth | -294.6% | -110.0% | -7.9% | -176.2% | -162.4% | 48.3% | 81.9% | -1.0% |
| |
| Shares outstanding (basic) [+] | 22.7 | 22.6 | 22.5 | 22.7 | 22.8 | 22.8 | 22.6 | 22.8 |
| Growth | -0.3% | -0.7% | -0.5% | -0.7% | -3.3% | -2.2% | 0.2% | 4.0% |
| Shares outstanding (diluted) [+] | 23.0 | 22.7 | 22.5 | 22.7 | 22.8 | 22.8 | 22.6 | 23.4 |
| Growth | 1.1% | -0.2% | -0.5% | -3.3% | -5.9% | -2.2% | 0.2% | 6.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |